News
Biogen partners with Sage Therapeutics on depression, movement disorder drugs
Biogen entered into an agreement to jointly develop and commercialise Sage Therapeutics' zuranolone for major depressive disorder (MDD) and postpartum depression (PDD), as well as SAGE-324 for essential tremor, the companies announced Friday. Under the deal, Biogen will pay...
News
AstraZeneca Says Forxiga Approved In Japan For Heart Failure
AstraZeneca’s Forxiga (dapagliflozin) has been approved in Japan for the treatment of patients with chronic heart failure (HF) who are receiving standard of care.
HF is a life-threatening chronic disease that prevents the heart from pumping sufficient levels of blood...
News
Lonza invests to expand manufacturing capabilities at Oregon site
Lonza AG has announced a significant investment to expand its particle engineering and drug product capabilities to meet increased market demand at its Bend, Oregon site. New suites for the development and clinical manufacture of drug product intermediates and...
News
Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing with U.S. FDA for EUA
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases...
Drug Research
Moderna Announces Amendment to Current Supply Agreement with UK Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19
Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the UK government for an additional 2 million doses of mRNA-1273,...
News
Wasdell Group strengthens PPFL business with ISO 13485 for medical devices
The Wasdell Group, a leading outsourcing partner to companies in the pharmaceutical and biotech sector, has announced that its Dundalk, Ireland facility has been certified to comply with the ISO 13485 standard for medical device manufacturing.
The ISO 13485 is...
News
Saudi Pharma in talks with Germanys CureVac for coronavirus shot
Saudi Pharmaceutical Industries and Medical Appliances Corp. have signed a non-binding memorandum of understanding with German biotech company CureVac NV to provide a Covid-19 vaccine in Saudi Arabia.
Shares in the two companies surged to the highest level in more...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read